This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012-2018.
Company Filing History:
Years Active: 2012-2018
Title: Konrad Huppi: Innovator in Cancer Diagnosis and Treatment
Introduction
Konrad Huppi is a notable inventor based in Herndon, VA (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of β-catenin related cancers. With a total of 2 patents, Huppi's work is paving the way for innovative therapeutic approaches.
Latest Patents
Huppi's latest patents include a method of diagnosing and treating cancer using B-catenin splice variants. This invention relates to methods and compositions for treating and diagnosing cancer, specifically targeting β-catenin related cancers. The methods generally involve administering RNAi constructs. Additionally, the invention encompasses methods for identifying CTNNB1 related cancer therapeutics.
Career Highlights
Konrad Huppi is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution allows him to contribute to groundbreaking research in cancer treatment and diagnosis.
Collaborations
Some of Huppi's notable coworkers include Mark Roth and Mark J Roth. Their collaboration in research projects enhances the potential for innovative solutions in the field of cancer therapeutics.
Conclusion
Konrad Huppi's contributions to cancer research through his patents and work at the National Institutes of Health highlight his commitment to advancing medical science. His innovative methods for diagnosing and treating cancer are crucial steps toward improving patient outcomes.